mHealth Regs: FDA Drafts Wellness, Accessories Guidance Docs
This article was originally published in The Gray Sheet
One proposal addresses regulatory policy for low-risk devices targeting "general wellness" and the other seeks to clarify how FDA intends to regulate products intended as accessories to devices. Mobile health developers have been on the lookout for both.
You may also be interested in...
Marc Scheineson, a former US FDA associate commissioner who now heads Alston & Bird’s food and drug law practice, offered insight into the agency's latest moves in regulating medical apps and what industry should watch for.
While the US agency's final guidance on medical device accessories provides sponsors assurance the agency could be more lenient in classifying their products, an industry group leader says the guidance left a lot of unanswered questions that will continue to create uncertainty for companies.
As new mobile health technologies such as wearables and mobile health apps come to market, the US FDA's new guidance is intended to give manufacturers a better idea of what kinds of low-risk wellness products the agency will allow to avoid regulation.